.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
UBS
Accenture
Citi
Boehringer Ingelheim
Colorcon
Chinese Patent Office
Cantor Fitzgerald
Moodys
Merck

Generated: December 15, 2017

DrugPatentWatch Database Preview

Ingredient-type: Nucleoside Analog

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Valeant BermudaZOVIRAXacyclovirOINTMENT;TOPICAL018604-001Mar 29, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Mylan Pharms IncZOVIRAXacyclovirCAPSULE;ORAL018828-001Jan 25, 1985ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Mylan Pharms IncZOVIRAXacyclovirTABLET;ORAL020089-001Apr 30, 1991ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
VibZOVIRAXacyclovirCREAM;TOPICAL021478-001Dec 30, 2002RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Mylan Pharms IncZOVIRAXacyclovirTABLET;ORAL020089-002Apr 30, 1991ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Mylan Pharms IncZOVIRAXacyclovirSUSPENSION;ORAL019909-001Dec 22, 1989ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Bausch And LombZIRGANganciclovirGEL;OPHTHALMIC022211-001Sep 15, 2009RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Mylan Pharms IncZIDOVUDINEzidovudineTABLET;ORAL078922-001Feb 14, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Cipla LtdZIDOVUDINEzidovudineSYRUP;ORAL077981-001Jun 26, 2008AARXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
AurobindoZIDOVUDINEzidovudineTABLET;ORAL077267-001Sep 19, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Teva
Mallinckrodt
McKinsey
Argus Health
McKesson
Moodys
Federal Trade Commission
Chubb
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot